Muramyl peptides as possible endogenous immunopharmacological mediators.
Synthetic N-acetylmuramyl-L-alanyl-D-isoglutamine, also called MDP for muramyl dipeptide, is a copy of a fragment of bacterial peptidoglycan. Soon after the recognition of MDP as being the minimal subunit responsible for the activity of Freund's complete adjuvant, a great number of derivatives were synthesized. Because of their very low molecular weight it was hoped that they could retain selectively certain of the numerous effects produced by complex bacterial agents. Evidence was gathered showing MDP's direct effect on lymphocytes and on macrophages. The ensuing studies reviewed that MDP and several of its derivatives have marked immunopharmacological and neuropharmacological activities. Thus, besides being adjuvants, they are capable of producing hyperthermia by acting directly on thermoregulation centers or by inducing in vivo and in vitro endogenous pyrogens (EP). More recently, Krueger et al have shown that slow-wave sleep (SWS) factor was a muramyl peptide of a molecular weight close to 1,000 daltons. They have also shown that MDP and several of its synthetic analogs had a somnogenic activity. It has previously been hypothesized that several of the immunological activities of the muramyl peptides could be due to biological mimicry with endogenous products. Recent observations argue in favor of the presence of an MDP bacterial structure in mammalian mediators which increase slow-wave sleep and/or produce fever. The implications of these findings will be discussed.
D000119:Acetylmuramyl-Alanyl-Isoglutamine / Q000502:physiology*; D000276:Adjuvants, Immunologic; D000818:Animals; D001833:Body Temperature Regulation; D006801:Humans; D008264:Macrophages / Q000502:physiology; D012157:Mononuclear Phagocyte System / Q000502:physiology; D011749:Pyrogens; D012890:Sleep / Q000502:physiology; D013329:Structure-Activity Relationship
D000276:Adjuvants, Immunologic; D011749:Pyrogens; D000119:Acetylmuramyl-Alanyl-Isoglutamine